Loading…
← CockpitCompetitor Analysis › MD Pediatrix Medical Group, Inc.Open in the cockpit ↗

Pediatrix Medical Group, Inc.MDCompetitor analysis, valuation and peers

United States · USD·Health Care›Medical/Nursing Services

Provider of physician staffing and services for neonatal, maternal-fetal and pediatric care in hospitals nationwide.

≈ A hospital-based neonatal/pediatric physician staffing companyMomentum leader 91
Mkt cap
$2.41B
US dollars, full cap
Free float
98%
of shares outstanding
$/day
$22.5M
20-day average traded
Fwd P/E
12.4×
forward earnings
ROIC−WACC
+10.5 pp
WACC 7.7%
Hurdle
-6 pp
Req g minus delivered
Next earnings
92 days
18 Feb 2027
Close · USD$30.84
1D-0.9%
1W-1.9%
1M+9.8%
3M+17.6%
6M+37.2%
YTD+44.2%
1Y+34.0%
ATR %3.3%
Beta0.37
52w lowhigh8.6% off high

What Pediatrix Medical does

Provider of physician staffing and services for neonatal, maternal-fetal and pediatric care in hospitals nationwide.

Bills insurers and Medicaid for the care its doctors give, and receives supplemental payments from hospitals when billings alone do not cover staffing costs. A large share of neonatal patients are on Medicaid, so state rates matter. Formerly Mednax, it sold its radiology and anesthesia units in 2020 to focus on babies and pregnancies.

In one line: A hospital-based neonatal/pediatric physician staffing company.

Products and services

  • Neonatology physician services
  • Maternal-fetal medicine services
  • Pediatric subspecialty services

Customers

  • Hospitals
  • Health systems
  • Patients (NICU/high-risk pregnancy)

Where it sits in the supply chain

  • Health care services
  • Physician staffing/services
  • Neonatal, maternal-fetal and pediatric…

What could go right

  • High-risk pregnancy/NICU volume growth
  • Hospital outsourcing of specialty physician staffing

What could go wrong

  • Hospital contract renewal/pricing risk
  • Physician recruitment/retention costs

Moat: narrow (scale, customer qualification). Large network of specialized neonatal/maternal-fetal physicians embedded in hospital contracts nationwide.

Headquarters: Sunrise, Florida · Founded: 1979 · Employees: 6,575

Named competitors

  • TeamHealth Holdings private or unlisted

Pediatrix Medical at a glance

Size Pediatrix Medical (MD) is a United States Health Care company (Medical/Nursing Services) with a market value of $2.41B, the 1665th largest of 3,085 United States companies the cockpit tracks. Shares closed at $30.84 on 18 Nov 2026.

Performance Over six months the shares gained 37.2%, against +19.1% for the median peer and -2.2% for the United States market (cap-weighted) — 6th highest of 21 in its peer set.

Growth Revenue grew 1.9% over the last twelve months (peer median +7.9%); the operating margin is 12.2% (peer median 7.6%).

Valuation It trades at 12.4× forward earnings against a peer median of 37.6× (2nd cheapest of 17).

Price implies For today's price to make sense, revenue must grow about -4% a year for seven years (Req g). Recent delivered growth is +2%, so the hurdle is -6 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 10.5 points above its cost of capital (7.7% WACC).

Short interest Short interest is 4.5% of the free float (30 Oct 2026).

Next results Next results expected around 18 Feb 2027 (exchange calendar; dates can move).

Relative performance

10012014021 May 202621 Aug 202618 Nov 2026MD 143Peer median 120
Six months, rebased to 100: Pediatrix Medical against the median of its 20 peers (local-currency closes).

Pediatrix Medical financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$1.96B$1.91B$2.01B$1.99B$1.97B
Revenue growth—-5%+1%+1%—
Gross profit$488M$472M$422M$385M$431M
EBITDA$262M$253M$216M$194M$236M
Net income$150M$165M-$99.1M-$60.4M$66.3M
Free cash flow$210M$253M$185M$104M$137M
Capital expenditure$17.3M$18.5M$22.0M$33.3M$29.7M
Total debt$612M$635M$662M$702M$717M

Quarterly statements and history in the cockpit →

Pediatrix Medical competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

0%+50%0%+20%AVAHADUS002044ALIF-BAZTANEOAGARWALEYE603882EMEIS300244VIJAYAACHCLALPATHLABPSNLSNDAAMBEAWGSAGLMCOV-BTDOCMD6-month return →1-month return →
Up and to the right = strong over both horizons. Pediatrix Medical is the large dot.

Fundamentals: revenue growth against valuation

0%+10%+20%25×50×75×AVAHADUS002044ALIF-BAZTANEOAGARWALEYE603882300244VIJAYAACHCLALPATHLABAMBEAWGSAGLMCOV-BMDRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Pediatrix Medical is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%AVAHADUS002044ALIF-BAZTAAGARWALEYE603882EMEIS300244VIJAYALALPATHLABAMBEAMCOV-BTDOCMDGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Pediatrix Medical is the large dot.

Pediatrix Medical competitors and peer comparison

How Pediatrix Medical compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Pediatrix Medical against its 20 peers (data as of 18 Nov 2026)
MeasureMDPeer medianRank in peer set
1-month return+9.8%-2.0%6th highest of 21
6-month return+37.2%+19.1%6th highest of 21
Distance from 52-week high-8.6%-19.6%9th highest of 21
Revenue growth (TTM)+1.9%+7.9%6th lowest of 21
Operating margin12.2%7.6%5th highest of 21
Forward P/E12.4×37.6×2nd cheapest of 17
Growth the price implies (Req g, 7 yrs)-4.4%13.6%2nd least demanding of 15
Growth delivered (Del g)+2.0%+11.0%3rd lowest of 15
Hurdle (Req g minus delivered)-6.4 pp+3.9 pp4th least demanding of 15
ROIC minus cost of capital+10.5 pp-1.6 pp2nd highest of 20
EV / EBITDA9.9×12.1×3rd cheapest of 14
Net debt / EBITDA0.7×2.9×5th least indebted of 15

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Pediatrix Medical MDUnited States$2.41B+37%+2%12%12.4×-4.4%+2.0%
Aveanna Healthcare AVAHUnited States$2.37B+41%+17%12%12.2×7.7%+10.2%
Addus HomeCare ADUSUnited States$2.25B+29%+12%11%16.2×4.0%+13.2%
Meinian Onehealth Healthcare 002044.SZChina$2.60B-27%-4%9%49.6×4.2%+5.7%
AddLife ALIF-B.STSweden$2.13B+15%+2%8%39.0×21.1%+14.6%
Azenta AZTAUnited States$2.03B+162%+5%-2%83.2×38.0%+3.9%
NeoGenomics NEOUnited States$1.98B+72%+11%-6%53.5×n/an/a
Dr. Agarwal's Health Care AGARWALEYE.NSIndia$1.86B+20%+26%15%77.1×43.0%+26.9%
Guangzhou Kingmed Diagnostics 603882.SSChina$1.86B+5%-3%7%29.9×5.4%-6.1%
Emeis EMEIS.PAFrance$1.78B-33%+4%3%n/a21.2%+8.5%
Dian Diagnostics 300244.SZChina$1.70B+1%-5%9%21.8×0.3%-1.1%
Vijaya Diagnostic Centre VIJAYA.NSIndia$1.69B+18%+24%32%63.0×40.4%+16.7%
Acadia Healthcare ACHCUnited States$3.49B+56%+4%10%18.6×n/an/a
Dr. Lal PathLabs LALPATHLAB.NSIndia$3.53B+15%+17%24%50.5×32.3%+11.8%
Personalis PSNLUnited States$1.62B+88%+17%-157%n/an/an/a
Sonida Senior Living SNDAUnited States$1.59B-11%+70%-8%n/an/an/a
Ambea AMBEA.STSweden$1.59B+28%+11%9%15.2×1.1%+7.7%
GeneDx WGSUnited States$1.56B+16%+15%-14%54.2×n/an/a
agilon health AGLUnited States$1.52B+12%+2%-2%34.1×n/an/a
Medicover MCOV-B.STSweden$3.87B+21%+3%7%36.1×19.6%+20.2%
Teladoc Health TDOCUnited States$1.47B+24%-2%-5%n/a-6.4%+18.3%

Questions

Who are Pediatrix Medical's main competitors?
Named competitors: TeamHealth Holdings (private or unlisted). The cockpit's measured peer set (industry) also includes Aveanna Healthcare (AVAH), Addus HomeCare (ADUS), Meinian Onehealth Healthcare (002044.SZ), AddLife (ALIF-B.ST), Azenta (AZTA), NeoGenomics (NEO).
Is Pediatrix Medical expensive compared with its peers?
On forward p/e it trades at 12.4× against a peer median of 37.6×, 2nd cheapest of 17 in its peer set. For today's price to make sense, revenue must grow about -4% a year for seven years (Req g). Recent delivered growth is +2%, so the hurdle is -6 pp: the price already allows for a slowdown.
How has Pediatrix Medical stock performed?
Over six months to 18 Nov 2026 the shares returned +37.2% against +19.1% for the median peer; over one year +34.0%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.